Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY
RUBY研究第一部分：多斯利单抗在原发性、晚期或复发性子宫内膜癌中的群体药代动力学和暴露-反应关系
期刊:British Journal of Clinical Pharmacology
影响因子:3
doi:10.1111/bcp.16325
Kuchimanchi, Mita; Jørgensen, Trine Lembrecht; Hanze, Eva; André, Thierry; Jain, Angela; Berton, Dominique; Alskär, Oskar; Zub, Oleksandr; Oaknin, Ana; Shahin, Mark S; Koliadi, Anthoula; Pothuri, Bhavana; Krivak, Tom; Pishchyk, Mikalai; Segev, Yakir; Backes, Floor J; Gennigens, Christine; Bouberhan, Sara; Zajic, Stefan; Melhem, Murad; Buscema, Joseph
